Levodopa for Parkinson's disease

N Engl J Med. 2009 Feb 26;360(9):935-6; author reply 936. doi: 10.1056/NEJMc082718.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / administration & dosage*
  • Antiparkinson Agents / adverse effects
  • Humans
  • Infusions, Parenteral
  • Levodopa / administration & dosage*
  • Levodopa / adverse effects
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Levodopa